Anthrax vaccine: a review (Q35643939)

9 August 2017

1 reference

title

Anthrax vaccine: a review (English)

1 reference

9 August 2017

John D Grabenstein

1

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Immunology and Allergy Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

23

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

713-730

1 reference

Anthrax vaccines: past, present and future

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

The Sverdlovsk anthrax outbreak of 1979

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Iraq's Biological Weapons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

1 reference

7 January 2021

Recognition and management of anthrax--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

ON THE RECOGNITION AND THERAPY OF SIMIAN WOOLSORTER'S DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Postexposure prophylaxis against experimental inhalation anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Demonstration of a capsule plasmid in Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Immunization studies with attenuated strains of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Purification of factor I and recognition of a third factor of the anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Crystal structure of the anthrax toxin protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Crystal structure of the anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Identification of the cellular receptor for anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Construction and characterization of a protective antigen-deficient Bacillus anthracis strain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax as a biological weapon, 2002: updated recommendations for management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax; a report of one hundred seventeen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Search for correlates of protective immunity conferred by anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Passive transfer of protection against Bacillus anthracis infection in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax. 'Borrowed immunity' may save future victims

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Recent advances in the development of an improved, human anthrax vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

The use of anthrax antigen to immunise man and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax: the disease in relation to vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Human live anthrax vaccine in the former USSR.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

The effectiveness and safety of vaccines against human anthrax: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

In vitro correlate of immunity in a rabbit model of inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Field Evaluation of a Human Anthrax Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Anthrax vaccine: short-term safety experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900093-6

7 January 2021

10.1016/S0889-8561(03)00093-6

Identifiers

DOI

1 reference

9 August 2017

1 reference